RecruitingNCT05824403

PAncreatic Disease Cohort of TOuLouse


Sponsor

University Hospital, Toulouse

Enrollment

300 participants

Start Date

Nov 28, 2023

Study Type

OBSERVATIONAL

Conditions

Summary

This study is a prospective cohort dedicated to pancreatic diseases excluding cancer. The aim is to develop positive or differential diagnostic tools between benign potentially malignant or malignant pancreatic pathologies. During this study the investigators collect data and biological samples to support research project.


Eligibility

Min Age: 18 Years

Plain Language Summary

Simplified for easier understanding

This study builds a registry of patients with inflammatory or cystic diseases of the pancreas — such as pancreatitis or pancreatic cysts — to better understand these conditions over time. By collecting detailed information from many patients, researchers hope to identify risk factors, improve diagnosis, and find better treatments for non-cancer pancreatic diseases. **You may be eligible if...** - You have a confirmed diagnosis of an inflammatory or cystic pancreatic condition (such as pancreatitis or a pancreatic cyst) - You are able to read and understand the study information - You have given written consent to participate - You are covered by a social security system **You may NOT be eligible if...** - You have pancreatic cancer - You have another active cancer of any type - You are pregnant or breastfeeding - You are under legal guardianship or protection Talk to your doctor to see if this trial is right for you.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.


Locations(1)

Rangueil hospital

Toulouse, France

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT05824403


Related Trials